You’ve done the hard part.You’ve secured regulatory approval. You’ve got two pilot sites running. You’ve even got distributor interest.But sales still aren’t landing the way you expected.Now you’ve got 90 days. Limited runway. Board pressure building.And you can only prioritise one move.So what do you focus on?Do you activate the distributor and push for reach?Do you hire commercial support to build structure?Do you refine your messaging and economic case?Or do you double down somewhere else entirely?In this episode, we break down how clinician founders should prioritise when everything feels urgent — and why most MedTech businesses stall not because the product isn’t strong, but because the commercial leverage isn’t.You’ll discover:Why regulatory approval is permission — not tractionThe difference between interest and evidence (and why only one protects your runway)The hidden risk of activating distributors too earlyWhy activity and progress are not the same thingThe decision framework that turns early traction into scalable momentumIf you’re a clinician building a Medical Device and trying to simplify your go-to-market strategy, this episode will challenge how you think about traction, revenue and exporting.Because the difference between a working prototype and an international MedTech business isn’t technical strength.It’s commercial proof.Hit play and decide what you would prioritise — before you hear what we would do.Message me via DM on LinkedinBook a 30 min discovery call for the Healthcare Export Accelerator ProgrammeThis podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.